chr2-30806969-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_144575.3(CAPN13):c.-33+333G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.739 in 152,196 control chromosomes in the GnomAD database, including 42,176 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.74 ( 42176 hom., cov: 32)
Consequence
CAPN13
NM_144575.3 intron
NM_144575.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.88
Publications
8 publications found
Genes affected
CAPN13 (HGNC:16663): (calpain 13) The calpains, calcium-activated neutral proteases, are nonlysosomal, intracellular cysteine proteases. The mammalian calpains include ubiquitous, stomach-specific, and muscle-specific proteins. The ubiquitous enzymes consist of heterodimers with distinct large, catalytic subunits associated with a common small, regulatory subunit. This gene encodes a member of the calpain large subunit family. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.833 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CAPN13 | ENST00000295055.12 | c.-33+333G>A | intron_variant | Intron 1 of 22 | 5 | NM_144575.3 | ENSP00000295055.8 | |||
| CAPN13 | ENST00000458085.6 | n.-119+333G>A | intron_variant | Intron 1 of 15 | 5 | ENSP00000416191.2 | ||||
| CAPN13 | ENST00000465960.2 | n.317+333G>A | intron_variant | Intron 2 of 8 | 5 | |||||
| CAPN13 | ENST00000485248.2 | n.-119+333G>A | intron_variant | Intron 1 of 5 | 3 | ENSP00000440723.1 |
Frequencies
GnomAD3 genomes AF: 0.739 AC: 112376AN: 152078Hom.: 42130 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
112376
AN:
152078
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.739 AC: 112473AN: 152196Hom.: 42176 Cov.: 32 AF XY: 0.736 AC XY: 54731AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
112473
AN:
152196
Hom.:
Cov.:
32
AF XY:
AC XY:
54731
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
34919
AN:
41536
American (AMR)
AF:
AC:
8605
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
2227
AN:
3470
East Asian (EAS)
AF:
AC:
4042
AN:
5178
South Asian (SAS)
AF:
AC:
3059
AN:
4814
European-Finnish (FIN)
AF:
AC:
8398
AN:
10578
Middle Eastern (MID)
AF:
AC:
212
AN:
294
European-Non Finnish (NFE)
AF:
AC:
48845
AN:
68000
Other (OTH)
AF:
AC:
1482
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1466
2932
4397
5863
7329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
838
1676
2514
3352
4190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2488
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.